Anshul  Maheshwari net worth and biography

Anshul Maheshwari Biography and Net Worth

CFO of SiBone

Anshul Maheshwari joins SI-BONE with over 15 years of experience in corporate finance, banking, treasury, and strategy. Most recently, Mr. Maheshwari served as Vice President of Finance, Investor Relations and Treasurer for Varian Medical Systems, a leading cancer care platform, where he held roles of increasing responsibilities since 2018. Prior to joining Varian Medical Systems, Mr. Maheshwari was Assistant Treasurer for Bechtel Corporation, a leading engineering and construction company. Prior to that, Mr. Maheshwari spent the majority of his career at Bank of America in corporate and investment banking.

What is Anshul Maheshwari's net worth?

The estimated net worth of Anshul Maheshwari is at least $3.92 million as of November 25th, 2025. Mr. Maheshwari owns 203,773 shares of SiBone stock worth more than $3,920,593 as of December 5th. This net worth estimate does not reflect any other assets that Mr. Maheshwari may own. Additionally, Mr. Maheshwari receives an annual salary of $705,690.00 as CFO at SiBone. Learn More about Anshul Maheshwari's net worth.

How old is Anshul Maheshwari?

Mr. Maheshwari is currently 44 years old. There are 6 older executives and no younger executives at SiBone. The oldest executive at SiBone is Mr. Anthony J. Recupero, President of Commercial Operations, who is 65 years old. Learn More on Anshul Maheshwari's age.

What is Anshul Maheshwari's salary?

As the CFO of SiBone, Mr. Maheshwari earns $705,690.00 per year. There are 2 executives that earn more than Mr. Maheshwari. The highest earning executive at SiBone is Ms. Laura A. Francis MBA, CEO & Director, who commands a salary of $1,260,000.00 per year. Learn More on Anshul Maheshwari's salary.

How do I contact Anshul Maheshwari?

The corporate mailing address for Mr. Maheshwari and other SiBone executives is 471 EL CAMINO REAL SUITE 101, SANTA CLARA CA, 95050. SiBone can also be reached via phone at (408) 207-0700 and via email at [email protected]. Learn More on Anshul Maheshwari's contact information.

Has Anshul Maheshwari been buying or selling shares of SiBone?

During the last quarter, Anshul Maheshwari has sold $181,012.33 of SiBone stock. Most recently, Anshul Maheshwari sold 100 shares of the business's stock in a transaction on Tuesday, November 25th. The shares were sold at an average price of $20.00, for a transaction totalling $2,000.00. Following the completion of the sale, the chief financial officer now directly owns 203,773 shares of the company's stock, valued at $4,075,460. Learn More on Anshul Maheshwari's trading history.

Who are SiBone's active insiders?

SiBone's insider roster includes Jeffrey Dunn (Director), Laura Francis (CEO), John Freund (Director), Jeryl Hilleman (Director), Gregory Hinckley (Director), E Jr (Director), Anshul Maheshwari (CFO), Mika Nishimura (Director), Michael Pisetsky (SVP), and Anthony Recupero (Insider). Learn More on SiBone's active insiders.

Are insiders buying or selling shares of SiBone?

In the last year, insiders at the sold shares 41 times. They sold a total of 278,971 shares worth more than $4,941,347.88. The most recent insider tranaction occured on November, 25th when CFO Anshul Maheshwari sold 100 shares worth more than $2,000.00. Insiders at SiBone own 4.0% of the company. Learn More about insider trades at SiBone.

Information on this page was last updated on 11/25/2025.

Anshul Maheshwari Insider Trading History at SiBone

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/25/2025Sell100$20.00$2,000.00203,773View SEC Filing Icon  
11/21/2025Sell1,200$20.01$24,012.00203,873View SEC Filing Icon  
11/17/2025Sell3,460$17.43$60,307.80205,073View SEC Filing Icon  
11/11/2025Sell2,601$18.33$47,676.33208,533View SEC Filing Icon  
10/2/2025Sell3,311$14.20$47,016.20211,134View SEC Filing Icon  
8/18/2025Sell3,461$15.57$53,887.77214,445View SEC Filing Icon  
7/2/2025Sell5,005$18.34$91,791.70217,078View SEC Filing Icon  
5/19/2025Sell2,424$19.48$47,219.52222,083View SEC Filing Icon  
5/16/2025Sell9,585$19.76$189,399.60224,507View SEC Filing Icon  
5/12/2025Sell4,937$19.02$93,901.74232,069View SEC Filing Icon  
5/7/2025Sell4,937$17.00$83,929.00265,356View SEC Filing Icon  
1/2/2025Sell5,304$13.91$73,778.64189,319View SEC Filing Icon  
11/18/2024Sell2,439$12.68$30,926.52194,623View SEC Filing Icon  
9/3/2024Sell1,414$16.35$23,118.90200,367View SEC Filing Icon  
8/16/2024Sell2,418$13.87$33,537.66198,762View SEC Filing Icon  
5/16/2024Sell2,441$15.14$36,956.74204,241View SEC Filing Icon  
4/2/2024Sell2,425$15.45$37,466.25205,516View SEC Filing Icon  
1/2/2024Sell1,470$20.92$30,752.40147,268View SEC Filing Icon  
11/16/2023Sell1,733$17.59$30,483.47148,738View SEC Filing Icon  
10/2/2023Sell1,244$21.15$26,310.60150,471View SEC Filing Icon  
8/16/2023Sell1,733$20.98$36,358.34151,715View SEC Filing Icon  
7/3/2023Sell1,244$26.70$33,214.80153,448View SEC Filing Icon  
6/7/2023Sell3,272$28.00$91,616.00154,692View SEC Filing Icon  
5/16/2023Sell3,624$24.48$88,715.52157,964View SEC Filing Icon  
4/3/2023Sell1,229$19.30$23,719.70159,697View SEC Filing Icon  
2/28/2023Sell1,986$21.00$41,706.00160,926View SEC Filing Icon  
2/16/2023Sell3,212$16.82$54,025.84162,912View SEC Filing Icon  
8/16/2022Sell1,709$17.29$29,548.6189,487View SEC Filing Icon  
5/16/2022Sell4,111$12.58$51,716.3890,748View SEC Filing Icon  
See Full Table

Anshul Maheshwari Buying and Selling Activity at SiBone

This chart shows Anshul Maheshwari's buying and selling at SiBone by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

SiBone Company Overview

SiBone logo
SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Read More

Today's Range

Now: $19.24
Low: $18.99
High: $19.61

50 Day Range

MA: $16.42
Low: $14.05
High: $19.67

2 Week Range

Now: $19.24
Low: $12.49
High: $20.05

Volume

532,706 shs

Average Volume

708,957 shs

Market Capitalization

$834.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.76